Finally, immunohistochemical analysis of xenograft tumor tissues showed that MWDT treatment in vivo reduced the expression of PTK2B, p-STAT3, and GPX4 (Fig. 7i), confirming the inhibition of this signaling pathway within the tumor microenvironment. The gene discussed is GPX4; the disease is neoplasm.